{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:39:22Z","timestamp":1792172362073,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.eucr.2025.103132","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:32:10Z","timestamp":1752906730000},"page":"103132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Immunotherapy-related cystitis induced by nivolumab: A case report and review of the literature"],"prefix":"10.1016","volume":"62","author":[{"given":"Yingying","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianqing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-4107","authenticated-orcid":false,"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.eucr.2025.103132_bib1","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","article-title":"Immune checkpoint inhibitors: basics and challenges","volume":"26","author":"Li","year":"2019","journal-title":"Curr Med Chem"},{"issue":"9","key":"10.1016\/j.eucr.2025.103132_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.eucr.2025.103132_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40265-022-01707-1","article-title":"Adverse events associated with immune checkpoint inhibitors: overview of systematic reviews","volume":"82","author":"Kanji","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.eucr.2025.103132_bib4","article-title":"Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: case report and literature review","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.eucr.2025.103132_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/nau.23459","article-title":"Expression of programmed death ligand\u20101 on bladder tissues is detected in a clinically and histologically well\u2010defined interstitial cystitis cohort","volume":"37","author":"Chen","year":"2017","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.eucr.2025.103132_bib6","article-title":"Non-bacterial cystitis with increased expression of programmed cell death ligand 1 in the urothelium: an unusual immune-related adverse event after Atezolizumab administration for metastatic breast cancer","volume":"14","author":"Obayashi","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.eucr.2025.103132_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s13691-017-0298-6","article-title":"A case of cystitis after administration of nivolumab","volume":"6","author":"Ozaki","year":"2017","journal-title":"Int Cancer Conf J"},{"issue":"5","key":"10.1016\/j.eucr.2025.103132_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/CMR.0000000000000765","article-title":"Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma","volume":"31","author":"Schneider","year":"2021","journal-title":"Melanoma Res"},{"key":"10.1016\/j.eucr.2025.103132_bib9","first-page":"97","article-title":"Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor","volume":"17","author":"Shimatani","year":"2018","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.eucr.2025.103132_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.757069","article-title":"Case report: a case of sintilimab-induced cystitis\/ureteritis and review of sintilimab-related adverse events","volume":"11","author":"Tu","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.eucr.2025.103132_bib11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/iju5.12211","article-title":"Non-bacterial cystitis with increased expression of programmed death-ligand 1 in the urothelium: an unusual immune-related adverse event during treatment with pembrolizumab for lung adenocarcinoma","volume":"3","author":"Ueki","year":"2020","journal-title":"IJU Case Rep"},{"issue":"4","key":"10.1016\/j.eucr.2025.103132_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/iju5.12286","article-title":"Improvement of urinary symptoms after bladder biopsy: a case of pathologically proven allergy\u2010related cystitis during administration of nivolumab","volume":"4","author":"Yajima","year":"2021","journal-title":"IJU Case Reports"},{"key":"10.1016\/j.eucr.2025.103132_bib13","first-page":"1","article-title":"Case reports of immune-related cystitis and the antibody combination hypothesis","author":"Zhang","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.eucr.2025.103132_bib14","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.2147\/OTT.S321965","article-title":"Immunotherapy-related cystitis: case report and review of the literature","volume":"14","author":"Zhu","year":"2021","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.eucr.2025.103132_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788629","article-title":"A case report of non-bacterial cystitis caused by immune checkpoint inhibitors","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.eucr.2025.103132_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001754","article-title":"Strategies for improving the management of immune-related adverse events","volume":"8","author":"Naing","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442025002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442025002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T19:57:01Z","timestamp":1757534221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214442025002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":16,"alternative-id":["S2214442025002037"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2025.103132","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy-related cystitis induced by nivolumab: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2025.103132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103132"}}